FILE:HSP/HSP-8K-20040428165548.txt.gz
EVENTS:	Financial statements and exhibits	Regulation FD Disclosure
TEXT:
ITEM: Financial statements and exhibits
ITEM: Regulation FD Disclosure
 
Item 7.  Financial Statements and Exhibits
(c)
                                 
Exhibits
99.1
                          
Revised page 31 to materials that the registrant intends to present in meetings with certain potential investors that were previously attached to a report on Form 8-K dated April 19, 2004.  These materials are being furnished pursuant to Item 9 hereof.
Item 9.  Regulation FD Disclosure
The registrant has corrected the disclosure in the first footnote on page 31 of the materials attached to a report on Form 8-K dated April 19, 2004 and attached the revised page 31 to this report as Exhibit 99.1.
Limitation of Incorporation by Reference
                In accordance with the general instruction B.2 of Form 8-K, the information in this report is furnished pursuant to Item 9 and shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section.
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 

Exhibit 99.1
 
Financial Outlook
 
 
Notes:
            
(1)   Includes impact on sales from expiration of Berlexdistribution agreement in December 2005. 2003 sales were $182 million.
                                               
(2)   Excluding one-time transition charges, which are estimated to be $50-60 million over the two-year period. Including these charges, projected earnings growth for this period would be 7-19%.
 


